vimarsana.com

Page 233 - இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India reports 42,766 new COVID-19 cases, 1,206 deaths in last 24 hours

India reports 42,766 new COVID-19 cases, 1,206 deaths in last 24 hours NEW DELHI : India reported 42,766 new COVID-19 cases in the last 24 hours, informed the Union Health Ministry on Saturday. India’s active caseload of COVID-19 cases is at 4,55,033. The active cases constitute 1.48 per cent of the total cases. The country also reported 1,206 deaths due to COVID-19 and with that, the cumulative fatalities in the country due to viral infection reached 4,07,145. Out of the people infected since the beginning of the pandemic, 2,99,33,538 patients have already recovered from COVID-19 and 45,254 recovered in the last 24 hours. This constitutes an overall recovery rate of 97.20 per cent, which is showing a sustained increasing trend.

ICMR survey finds 7% adolescents have experimented with tobacco | India News

Representative image BENGALURU: Seven per cent of adolescents between 15 years and 17 years in India experimented with smoking or smokeless tobacco, according to a study by the Indian Council of Medical Research (ICMR) and National Centre for Disease Informatics & Research (NCDIR), Bengaluru. The study report, published in the June 2021 issue of the British Medical Journal, highlights the risk factors for non-communicable diseases among adolescents. One in every 10 adolescents in India experimented with smoke or smokeless forms of tobacco, the study says, adding that adolescents from urban areas had a higher proportion of risk factors than those from rural areas. The research, conducted in 2017-18, had 1,531 adolescents across the country. Of them, 3.1% reported current use of any form of tobacco, higher in rural areas (3.6%) and among boys (5.5 %). The study highlighted that one-fifth of adolescents reported noticing teachers or school staff smoking on the premises.

ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation

ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation The trial, India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy) , will be a multi-centre, adaptive platform trial on COVID patients, ICMR said on Friday. Outlook Web Desk 10 July 2021, Last Updated at 11:42 am PTI Outlook Web Desk 2021-07-10T11:11:35+05:30 ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation outlookindia.com 2021-07-10T11:42:22+05:30 The Indian Council of Medical Research (ICMR) has proposed a collaborative endeavour  of conducting a clinical trial for randomised evaluation of COVID-19 therapy with the University of Oxford. ICMR  expects the hospitals to come up with expression of intent .

MP s Krishi Vigyan Kendra urges ICMR to prescribe Kadaknath therapy for post COVID recovery

MP s Krishi Vigyan Kendra urges ICMR to prescribe Kadaknath therapy for post COVID recovery ANI | Updated: Jul 10, 2021 11:40 IST Jhabua (Madhya Pradesh) [India], July 10 (ANI): Krishi Vigyan Kendra of Jhabua in Madhya Pradesh has urged the Indian Council of Medical Research (ICMR) to prescribe Kadaknath therapy from the state s black-feathered poultry breed for those recovering from post-COVID-19 complications. In the letter to the Director-General of ICMR, Krishi Vigyan Kendra senior scientist and head has claimed that Kadaknath (a rare breed of black chicken) based products-meat, eggs and soup, could provide necessary nutritional support for the recovery of post-COVID-19 patients. As we know that nutritional therapy appears as the first line of treatment for the post-COVID-19 patient and optimum intake of all nutrients, mainly those playing crucial roles in the immune system, should be given through diverse and well-balanced diet, t

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.